Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5

We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, 10.1007/s11912-020-0880-5. We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Reports.

Detalles Bibliográficos
Autores principales: Böhmer, Dirk, Grün, Arne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817564/
https://www.ncbi.nlm.nih.gov/pubmed/33471212
http://dx.doi.org/10.1007/s11912-020-01012-8
_version_ 1783638666551230464
author Böhmer, Dirk
Grün, Arne
author_facet Böhmer, Dirk
Grün, Arne
author_sort Böhmer, Dirk
collection PubMed
description We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, 10.1007/s11912-020-0880-5. We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Reports.
format Online
Article
Text
id pubmed-7817564
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-78175642021-01-25 Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5 Böhmer, Dirk Grün, Arne Curr Oncol Rep Letter to the Editor We comment on the paper of Di Maria Jiang et al. published in Current Oncology Reports 2020, 10.1007/s11912-020-0880-5. We disagree on a major recommendation of the authors because of lacking evidence. This response is considered to be important for readers of Current Oncology Reports. Springer US 2021-01-20 2021 /pmc/articles/PMC7817564/ /pubmed/33471212 http://dx.doi.org/10.1007/s11912-020-01012-8 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Böhmer, Dirk
Grün, Arne
Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
title Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
title_full Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
title_fullStr Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
title_full_unstemmed Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
title_short Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
title_sort lacking evidence to recommend neoadjuvant chemotherapy and definitive radiotherapy in muscle-invasive bladder cancer: in response to: trimodality therapy for muscle-invasive bladder cancer: recent advances and unanswered questions published by di maria jiang et al. current oncology reports 2020, https://doi.org/10.1007/s11912-020-0880-5
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817564/
https://www.ncbi.nlm.nih.gov/pubmed/33471212
http://dx.doi.org/10.1007/s11912-020-01012-8
work_keys_str_mv AT bohmerdirk lackingevidencetorecommendneoadjuvantchemotherapyanddefinitiveradiotherapyinmuscleinvasivebladdercancerinresponsetotrimodalitytherapyformuscleinvasivebladdercancerrecentadvancesandunansweredquestionspublishedbydimariajiangetalcurrentoncologyreports2020htt
AT grunarne lackingevidencetorecommendneoadjuvantchemotherapyanddefinitiveradiotherapyinmuscleinvasivebladdercancerinresponsetotrimodalitytherapyformuscleinvasivebladdercancerrecentadvancesandunansweredquestionspublishedbydimariajiangetalcurrentoncologyreports2020htt

Ejemplares similares